Find Businesses & Services

CONJUGON in Madison, Wisconsin

CONJUGON's Website

(608) 441-2890

505 S ROSA RD STE 29
Madison, WI 53719-6006

http://www.conjugon.com

Map & Directions

Company Description:

conjugon, inc. is a biotechnology company that is developing novel antimicrobial therapeutics to combat the growing epidemic of antibiotic-resistant bacteria. conjugon, based on research done at the university of wisconsin-madison, is located in the university research park in madison, wisconsin.

Services Offered:

Conjugon Antibacterial Antimicrobial Drug Development Biotechnology Antibiotic Resistance Drug Resistance Madison Wisconsin
Richard Burgess Marcin Filutowicz Sal Braico Hideki Suzuki Plasmid Bacteria University Research Park Mg&e Innovation Center Dna

Web Results:

Conjugon.com/contact.htm
Home About us Technologies News & Events Careers Contact Contact Location ConjuGon Inc. 505 S. Rosa Rd Suite 29 Madison, WI 53719 Phone: (608) 441-2794 Fax: (608) 441-2891 Email:info@conjugon.com For directions Click Here 2010 ConjuGon Inc. All rights reserved. ...
Technologies
pseudoHome About us Technologies News & Events Careers Contact Technologies ConjuGon, Inc. is developing novel technologies that use harmless bacteria as drugs. Currently, the company is advancing the technology of Bacterial Interference for the prevention of Catheter-Associated Urinary Tract Infectio...
Conjugon.com/careers.htm
Home About us Technologies News & Events Careers Contact Careers There are currently no positions available. Please check back at a later date. 2010 ConjuGon Inc. All rights reserved. ...
Conjugon.com/home.htm
Home About us Technologies News & Events Careers Contact Home Welcome to ConjuGon, Inc Our mission is to develop fundamentally new ways to prevent and treat bacterial infections. Bacterial infections cause millions of people to be hospitalized each year in the U.S. and result in nearly 100,000 d...
Conjugon.com/news.htm
Home About us Technologies News & Events Careers Contact News & Events Press Releases April 2009 FDA Accepts IND for ConjuGon' C-1205 - Prevention of Urinary Tract Infections. October 2008 ConjuGon to Receive $2.4 Million for Defense R & D. December 2007 ConjuGon to Receive $1.2 Million ...

Business Information:

In Business Since:2001
Business Sector:Residential, Commercial
Found any discrepancies in your company profile? Request to update the information